Genome Editing in Human iPS Cells to Study and Cure Disease
Human iPS (induced pluripotent stem) cells have the potential to allow us to study diseases in virtually any type of human cell, and develop cell transplantation-based therapies. Our team is developing and improving genome editing technology in iPS cells. We are developing novel isogenic iPS cell-based disease models, and correcting mutations in iPS cells from patients, a critical step in transplantation-based therapies. Our current focus is on diseases affecting cardiomyocytes and hepatocytes. →More
2020. 4. 1. Undergraduate students, Terumi Ono joins the lab
2019. 12. 5. Contribute to the Standard Protocols on Genome Editing (Yodosha)
2019. 11. 1. Highlighted in HEALTHIEST in English version (published by Yakult)
2019. 8. 1. Highlighted in the Chichi magazine
2019. 7. 10. Highlighted in HEALTHIEST (published by Yakult)
2020. 5. 17. Open labs for graduate and undergraduate students.